Xu, J., Teran-Garcia, M., Park, J
As a result of new terminologies and updated nomenclatures, many studies were carried out to assess the appropriateness of using the existing ICD NAFLD and NASH codes to code MASLD and MASH, respectively (Song et al
The timing of droplet placement was synchronized with natural inhalation to allow for drops to settle on the olfactory and respiratory epithelium within the nasal cavity [9]
Reducing appetite: Research has found that Melanotan can reduce hunger and change food preferences towards less fatty foods [6]
Coverage is limited
The reality: Injectables Still set the efficacy ceiling Strongest outcomes + label support Oral drugs Lower efficacy (~1113%) But expand the market significantly Key insight: This is not one oral category Oral semaglutide requires fasting + waiting Orforglipron taken anytime The winner may be the least inconvenient drug, not the most effective The Hidden Problem: Persistence This is the part almost no one talks about: Only ~24.5% of patients remain on therapy at 12 months ~20% switch therapies within a year After stopping: Weight regain 0.8 kg per month Let that sink in
